Clinical Trial Update: Irinotecan in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This entry notes completion of a Phase 2 trial evaluating irinotecan for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED